{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:56:14Z","timestamp":1794956174528,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA281286-01"],"award-info":[{"award-number":["R01CA281286-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA281286-01"],"award-info":[{"award-number":["R01CA281286-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010850","name":"AHNS | Research and Education Foundation of the American Head and Neck Society","doi-asserted-by":"publisher","award":["Pilot Grant Award"],"award-info":[{"award-number":["Pilot Grant Award"]}],"id":[{"id":"10.13039\/100010850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["F32DE029990-01"],"award-info":[{"award-number":["F32DE029990-01"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Surgical ablation or broad radiation of tumor-draining lymph nodes can eliminate the primary tumor response to immunotherapy, highlighting the crucial role of these nodes in mediating the primary tumor response. Here, we show that immunoradiotherapy efficacy is dependent on treatment sequence and migration of modulated dendritic cells from tumor to sentinel lymph nodes. Using a tamoxifen-inducible reporter paired with CITE-sequencing in a murine model of oral cancer, we comprehensively characterize tumor immune cellular migration through lymphatic channels to sentinel lymph nodes at single-cell resolution, revealing a unique immunologic niche defined by distinct cellular phenotypic and transcriptional profiles. Through a structured approach of sequential immunomodulatory radiotherapy and checkpoint inhibition, we show that sequenced, lymphatic-sparing, tumor-directed radiotherapy followed by PD-1 inhibition achieves complete and durable tumor responses. Mechanistically, this treatment approach enhances migration of activated CCR7+ dendritic cell surveillance across the tumor-sentinel lymph node axis, revealing a shift from their canonical role in promoting tolerance to driving antitumor immunity. Overall, this work supports rationally sequencing immune-sensitizing, lymphatic-preserving, tumor-directed radiotherapy followed by immune checkpoint inhibition to optimize tumor response to immunoradiotherapy by driving activated dendritic cells to draining sentinel lymph nodes.<\/jats:p>","DOI":"10.1038\/s41467-025-61780-4","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:41:49Z","timestamp":1752774109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The tumor-sentinel lymph node immuno-migratome reveals CCR7\u207a dendritic cells drive response to sequenced immunoradiotherapy"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9936-1695","authenticated-orcid":false,"given":"Robert","family":"Saddawi-Konefka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyam Al","family":"Msari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Philips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed","family":"Sadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Clubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7211-5539","authenticated-orcid":false,"given":"Sarah","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Fassardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-4699","authenticated-orcid":false,"given":"Riley","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Franiak","family":"Pietryga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5078-813X","authenticated-orcid":false,"given":"Farhoud","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9441-9547","authenticated-orcid":false,"given":"Shiruyeh","family":"Schokrpur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan S.","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Allevato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey E.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanond A.","family":"Nasamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Chilin-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6548-9658","authenticated-orcid":false,"given":"Sara Brin","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-5930","authenticated-orcid":false,"given":"Shawn M.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-5947","authenticated-orcid":false,"given":"Bernard A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Bryan","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Silvio","family":"Gutkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-6761","authenticated-orcid":false,"given":"Joseph A.","family":"Califano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"61780_CR1","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","volume":"398","author":"MD Mody","year":"2021","unstructured":"Mody, M. D., Rocco, J. W., Yom, S. S., Haddad, R. I. & Saba, N. F. Head and neck cancer. Lancet 398, 2289\u20132299 (2021).","journal-title":"Lancet"},{"key":"61780_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"61780_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.738626","volume":"11","author":"R Saddawi-Konefka","year":"2021","unstructured":"Saddawi-Konefka, R. et al. Defining the role of immunotherapy in the curative treatment of locoregionally advanced head and neck cancer: promises, challenges, and opportunities. Front. Oncol. 11, 738626 (2021).","journal-title":"Front. Oncol."},{"key":"61780_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","volume":"22","author":"NY Lee","year":"2021","unstructured":"Lee, N. Y. et al. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Oncol. 22, 450\u2013462 (2021).","journal-title":"Lancet Oncol."},{"key":"61780_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S1470-2045(24)00100-1","volume":"25","author":"JP Machiels","year":"2024","unstructured":"Machiels, J. P. et al. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial. Lancet Oncol. 25, 572\u2013587 (2024).","journal-title":"Lancet Oncol."},{"key":"61780_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ccell.2024.05.015","volume":"42","author":"R Saddawi-Konefka","year":"2024","unstructured":"Saddawi-Konefka, R., Schokrpur, S. & Gutkind, J. S. Let it be: Preserving tumor-draining lymph nodes in the era of immuno-oncology. Cancer Cell 42, 930\u2013933 (2024).","journal-title":"Cancer Cell"},{"key":"61780_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s43018-022-00450-6","volume":"3","author":"LB Darragh","year":"2022","unstructured":"Darragh, L. B. et al. A phase I\/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC. Nat. Cancer 3, 1300\u20131317 (2022).","journal-title":"Nat. Cancer"},{"key":"61780_CR8","doi-asserted-by":"crossref","unstructured":"Leidner, R. et al. Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma. J. Immunother. Cancer 9, e002485 (2021).","DOI":"10.1136\/jitc-2021-002485"},{"key":"61780_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ijrobp.2023.04.029","volume":"117","author":"TM Ma","year":"2023","unstructured":"Ma, T. M. et al. High recurrence for hpv-positive oropharyngeal cancer with neoadjuvant radiation therapy to gross disease plus immunotherapy: analysis from a prospective phase Ib\/II clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 117, 348\u2013354 (2023).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"61780_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31941-w","volume":"13","author":"R Saddawi-Konefka","year":"2022","unstructured":"Saddawi-Konefka, R. et al. Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. Nat. Commun. 13, 4298 (2022).","journal-title":"Nat. Commun."},{"key":"61780_CR11","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2008.20.8777","volume":"28","author":"FJ Civantos","year":"2010","unstructured":"Civantos, F. J. et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J. Clin. Oncol. 28, 1395\u20131400 (2010).","journal-title":"J. Clin. Oncol."},{"key":"61780_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","volume":"390","author":"J de Boniface","year":"2024","unstructured":"de Boniface, J. et al. Omitting axillary dissection in breast cancer with sentinel-node metastases. N. Engl. J. Med. 390, 1163\u20131175 (2024).","journal-title":"N. Engl. J. Med."},{"key":"61780_CR13","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1200\/JCO.20.03637","volume":"39","author":"Y Hasegawa","year":"2021","unstructured":"Hasegawa, Y. et al. Neck dissections based on sentinel lymph node navigation versus elective neck dissections in early oral cancers: a randomized, multicenter, and noninferiority trial. J. Clin. Oncol. 39, 2025\u20132036 (2021).","journal-title":"J. Clin. Oncol."},{"key":"61780_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton, D. L. et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N. Engl. J. Med. 370, 599\u2013609 (2014).","journal-title":"N. Engl. J. Med."},{"key":"61780_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1001\/jamaoto.2024.1332","volume":"150","author":"C Schilling","year":"2024","unstructured":"Schilling, C., Sahovaler, A. & Lai, S. Y. Sentinel node biopsy in oral cancer-indications, analysis, and outcomes. JAMA Otolaryngol. Head. Neck Surg. 150, 634 (2024).","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"61780_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nri1919","volume":"6","author":"AJ Cochran","year":"2006","unstructured":"Cochran, A. J. et al. Tumour-induced immune modulation of sentinel lymph nodes. Nat. Rev. Immunol. 6, 659\u2013670 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"61780_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2023.09.006","volume":"10","author":"I Delclaux","year":"2024","unstructured":"Delclaux, I., Ventre, K. S., Jones, D. & Lund, A. W. The tumor-draining lymph node as a reservoir for systemic immune surveillance. Trends Cancer 10, 28\u201337 (2024).","journal-title":"Trends Cancer"},{"key":"61780_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13471-0","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4. Nat. Commun. 10, 5546 (2019).","journal-title":"Nat. Commun."},{"key":"61780_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1074-7613(02)00365-5","volume":"17","author":"S Jung","year":"2002","unstructured":"Jung, S. et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17, 211\u2013220 (2002).","journal-title":"Immunity"},{"key":"61780_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1084\/jem.20041236","volume":"200","author":"MJ Miller","year":"2004","unstructured":"Miller, M. J., Safrina, O., Parker, I. & Cahalan, M. D. Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J. Exp. Med. 200, 847\u2013856 (2004).","journal-title":"J. Exp. Med."},{"key":"61780_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djs629","volume":"105","author":"SC Formenti","year":"2013","unstructured":"Formenti, S. C. & Demaria, S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J. Natl. Cancer Inst. 105, 256\u2013265 (2013).","journal-title":"J. Natl. Cancer Inst."},{"key":"61780_CR22","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/S1470-2045(15)00007-8","volume":"16","author":"AB Sharabi","year":"2015","unstructured":"Sharabi, A. B., Lim, M., DeWeese, T. L. & Drake, C. G. Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy. Lancet Oncol. 16, e498\u2013509 (2015).","journal-title":"Lancet Oncol."},{"key":"61780_CR23","doi-asserted-by":"crossref","unstructured":"Barsoumian, H. B. et al. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma. J. Immunother. Cancer 8, e000537 (2020).","DOI":"10.1136\/jitc-2020-000537"},{"key":"61780_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41571-023-00782-x","volume":"20","author":"L Galluzzi","year":"2023","unstructured":"Galluzzi, L., Aryankalayil, M. J., Coleman, C. N. & Formenti, S. C. Emerging evidence for adapting radiotherapy to immunotherapy. Nat. Rev. Clin. Oncol. 20, 543\u2013557 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"61780_CR25","doi-asserted-by":"publisher","first-page":"e1395996","DOI":"10.1080\/2162402X.2017.1395996","volume":"7","author":"M Morisada","year":"2018","unstructured":"Morisada, M. et al. PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation. Oncoimmunology 7, e1395996 (2018).","journal-title":"Oncoimmunology"},{"key":"61780_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk0642","volume":"16","author":"JC Jagodinsky","year":"2024","unstructured":"Jagodinsky, J. C. et al. Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade. Sci. Transl. Med. 16, eadk0642 (2024).","journal-title":"Sci. Transl. Med."},{"key":"61780_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add7446","volume":"8","author":"S Tadepalli","year":"2023","unstructured":"Tadepalli, S. et al. Rapid recruitment and IFN-I-mediated activation of monocytes dictate focal radiotherapy efficacy. Sci. Immunol. 8, eadd7446 (2023).","journal-title":"Sci. Immunol."},{"key":"61780_CR28","unstructured":"Wang, L. et al. Radiotherapy and immunology. J. Exp. Med. 22, e20232101 (2024)."},{"key":"61780_CR29","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.ijrobp.2023.12.046","volume":"118","author":"AJ Wisdom","year":"2024","unstructured":"Wisdom, A. J. et al. The next chapter in immunotherapy and radiation combination therapy: cancer-specific perspectives. Int. J. Radiat. Oncol. Biol. Phys. 118, 1404\u20131421 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"61780_CR30","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41590-023-01529-7","volume":"24","author":"VH Wu","year":"2023","unstructured":"Wu, V. H. et al. The GPCR-Galpha(s)-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure. Nat. Immunol. 24, 1318\u20131330 (2023).","journal-title":"Nat. Immunol."},{"key":"61780_CR31","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S1470-2045(21)00149-2","volume":"22","author":"NK Altorki","year":"2021","unstructured":"Altorki, N. K. et al. Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial. Lancet Oncol. 22, 824\u2013835 (2021).","journal-title":"Lancet Oncol."},{"key":"61780_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44195-x","volume":"14","author":"NK Altorki","year":"2023","unstructured":"Altorki, N. K. et al. Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nat. Commun. 14, 8435 (2023).","journal-title":"Nat. Commun."},{"key":"61780_CR33","doi-asserted-by":"crossref","unstructured":"Rodrigues, A. et al. Computer-assisted tumor grading, validation of PD-L1 scoring, and quantification of CD8-positive immune cell density in urothelial carcinoma, a visual guide for pathologists using QuPath. Surg. Exp. Pathol. 5, 12 (2022).","DOI":"10.1186\/s42047-022-00112-y"},{"key":"61780_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101481","volume":"52","author":"AE Marciscano","year":"2021","unstructured":"Marciscano, A. E. & Anandasabapathy, N. The role of dendritic cells in cancer and anti-tumor immunity. Semin. Immunol. 52, 101481 (2021).","journal-title":"Semin. Immunol."},{"key":"61780_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1158\/2326-6066.CIR-13-0102","volume":"1","author":"I Mellman","year":"2013","unstructured":"Mellman, I. Dendritic cells: master regulators of the immune response. Cancer Immunol. Res. 1, 145\u2013149 (2013).","journal-title":"Cancer Immunol. Res."},{"key":"61780_CR36","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1002\/eji.200737400","volume":"37","author":"RM Steinman","year":"2007","unstructured":"Steinman, R. M. Dendritic cells: understanding immunogenicity. Eur. J. Immunol. 37, S53\u201360 (2007).","journal-title":"Eur. J. Immunol."},{"key":"61780_CR37","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1158\/1078-0432.CCR-23-3477","volume":"30","author":"S Saito","year":"2024","unstructured":"Saito, S. et al. Targeting dendritic cell dysfunction to circumvent anti-PD1 resistance in head and neck cancer. Clin. Cancer Res. 30, 1934\u20131944 (2024).","journal-title":"Clin. Cancer Res."},{"key":"61780_CR38","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.4049\/jimmunol.1800412","volume":"201","author":"J He","year":"2018","unstructured":"He, J. et al. Blocking matrix metalloproteinase-9 abrogates collagen-induced arthritis via inhibiting dendritic cell migration. J. Immunol. 201, 3514\u20133523 (2018).","journal-title":"J. Immunol."},{"key":"61780_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44787-1","volume":"15","author":"CYC Lee","year":"2024","unstructured":"Lee, C. Y. C. et al. Tumour-retained activated CCR7(+) dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity. Nat. Commun. 15, 682 (2024).","journal-title":"Nat. Commun."},{"key":"61780_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1182\/blood-2007-05-090613","volume":"111","author":"JH Yen","year":"2008","unstructured":"Yen, J. H., Khayrullina, T. & Ganea, D. PGE2-induced metalloproteinase-9 is essential for dendritic cell migration. Blood 111, 260\u2013270 (2008).","journal-title":"Blood"},{"key":"61780_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.727433","volume":"11","author":"H Shibata","year":"2021","unstructured":"Shibata, H., Saito, S. & Uppaluri, R. Immunotherapy for head and neck cancer: a paradigm shift from induction chemotherapy to neoadjuvant immunotherapy. Front. Oncol. 11, 727433 (2021).","journal-title":"Front. Oncol."},{"key":"61780_CR42","doi-asserted-by":"crossref","unstructured":"Fransen, M. F. et al. Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy. JCI Insight. 3, e124507 (2018).","DOI":"10.1172\/jci.insight.124507"},{"key":"61780_CR43","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.1158\/1078-0432.CCR-17-3427","volume":"24","author":"AE Marciscano","year":"2018","unstructured":"Marciscano, A. E. et al. Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy. Clin. Cancer Res. 24, 5058\u20135071 (2018).","journal-title":"Clin. Cancer Res."},{"key":"61780_CR44","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1021\/acsinfecdis.8b00111","volume":"4","author":"A Bogoslowski","year":"2018","unstructured":"Bogoslowski, A. & Kubes, P. Lymph nodes: the unrecognized barrier against pathogens. ACS Infect. Dis. 4, 1158\u20131161 (2018).","journal-title":"ACS Infect. Dis."},{"key":"61780_CR45","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.cell.2012.07.021","volume":"150","author":"W Kastenmuller","year":"2012","unstructured":"Kastenmuller, W., Torabi-Parizi, P., Subramanian, N., Lammermann, T. & Germain, R. N. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 150, 1235\u20131248 (2012).","journal-title":"Cell"},{"key":"61780_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32011-2","volume":"8","author":"R Seelige","year":"2018","unstructured":"Seelige, R. et al. Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection. Sci. Rep. 8, 13670 (2018).","journal-title":"Sci. Rep."},{"key":"61780_CR47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1084\/jem.90.6.555","volume":"90","author":"RO Smith","year":"1949","unstructured":"Smith, R. O. & Wood, W. B. Jr Cellular mechanisms of antibacterial defense in lymph nodes; pathogenesis of acute bacterial lymphadenitis. J. Exp. Med. 90, 555\u2013566 (1949).","journal-title":"J. Exp. Med."},{"key":"61780_CR48","doi-asserted-by":"crossref","unstructured":"Leal, J. M. et al. Innate cell microenvironments in lymph nodes shape the generation of T cell responses during type I inflammation. Sci. Immunol. 6, eabb9435 (2021).","DOI":"10.1126\/sciimmunol.abb9435"},{"key":"61780_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg8249","volume":"8","author":"C Pirillo","year":"2023","unstructured":"Pirillo, C. et al. Cotransfer of antigen and contextual information harmonizes peripheral and lymph node conventional dendritic cell activation. Sci. Immunol. 8, eadg8249 (2023).","journal-title":"Sci. Immunol."},{"key":"61780_CR50","first-page":"844","volume":"123","author":"JF Idoyaga","year":"2013","unstructured":"Idoyaga, J. F. et al. Specialized role of migratory dendritic cells in peripheral tolerance induction.  J. Clin. Investig. 123, 844\u2013854 (2013).","journal-title":"J. Clin. Investig."},{"key":"61780_CR51","doi-asserted-by":"crossref","unstructured":"Blair, T. C. et al. Fluorescent tracking identifies key migratory dendritic cells in the lymph node after radiotherapy. Life Sci. Alliance 5, e202101337 (2022).","DOI":"10.26508\/lsa.202101337"},{"key":"61780_CR52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","volume":"21","author":"I Heras-Murillo","year":"2024","unstructured":"Heras-Murillo, I., Adan-Barrientos, I., Galan, M., Wculek, S. K. & Sancho, D. Dendritic cells as orchestrators of anticancer immunity and immunotherapy. Nat. Rev. Clin. Oncol. 21, 257\u2013277 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"61780_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112260","volume":"194","author":"S Mondal","year":"2020","unstructured":"Mondal, S., Adhikari, N., Banerjee, S., Amin, S. A. & Jha, T. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview. Eur. J. Med. Chem. 194, 112260 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"61780_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.coi.2017.06.003","volume":"47","author":"M Saxena","year":"2017","unstructured":"Saxena, M. & Bhardwaj, N. Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines. Curr. Opin. Immunol. 47, 35\u201343 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"61780_CR55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao, T. et al. Vaccine adjuvants: mechanisms and platforms. Signal Transduct. Target Ther. 8, 283 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"61780_CR56","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","volume":"7","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z., Liu, X., Chen, D. & Yu, J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduct. Target Ther. 7, 258 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"61780_CR57","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 18, e3000411 (2020).","journal-title":"PLoS Biol."},{"key":"61780_CR58","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.18632\/oncotarget.23751","volume":"9","author":"P Zolkind","year":"2018","unstructured":"Zolkind, P. et al. Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma. Oncotarget 9, 4109\u20134119 (2018).","journal-title":"Oncotarget"},{"key":"61780_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1158\/1940-6207.CAPR-08-0147","volume":"2","author":"R Czerninski","year":"2009","unstructured":"Czerninski, R., Amornphimoltham, P., Patel, V., Molinolo, A. A. & Gutkind, J. S. Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model. Cancer Prev. Res. 2, 27\u201336 (2009).","journal-title":"Cancer Prev. Res."},{"key":"61780_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"61780_CR61","doi-asserted-by":"publisher","first-page":"e0197842","DOI":"10.1371\/journal.pone.0197842","volume":"13","author":"KM Anderson","year":"2018","unstructured":"Anderson, K. M. et al. Molecular Imaging of endometrial sentinel lymph nodes utilizing fluorescent-labeled Tilmanocept during robotic-assisted surgery in a porcine model. PLoS ONE 13, e0197842 (2018).","journal-title":"PLoS ONE"},{"key":"61780_CR62","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/lary.31014","volume":"134","author":"T Guo","year":"2024","unstructured":"Guo, T. et al. Fluorescent guided sentinel lymph mapping of the oral cavity with fluorescent-labeled tilmanocept. Laryngoscope 134, 1299\u20131307 (2024).","journal-title":"Laryngoscope"},{"key":"61780_CR63","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61780_CR64","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.immuni.2015.12.006","volume":"44","author":"J Godec","year":"2016","unstructured":"Godec, J. et al. Compendium of immune signatures identifies conserved and species-specific biology in response to inflammation. Immunity 44, 194\u2013206 (2016).","journal-title":"Immunity"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61780-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61780-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61780-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:29:29Z","timestamp":1757258969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61780-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61780"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61780-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6578"}}